A Randomized Controlled Trial of a Nutritional Intervention for Endometriosis
1 other identifier
interventional
120
1 country
1
Brief Summary
This randomized, controlled study will investigate the efficacy of a dietary intervention for women with endometriosis. Participants will be randomly assigned to follow a whole food plant-based (intervention) diet or stay on their usual (control) diet for 12 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2025
CompletedFirst Posted
Study publicly available on registry
July 29, 2025
CompletedStudy Start
First participant enrolled
November 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2029
April 28, 2026
November 1, 2025
2.9 years
July 22, 2025
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total pain score
Change in total VAS for dysmenorrhea, dyspareunia and non-menstrual pelvic pain
12 weeks
Study Arms (2)
Experimental arm which will receive the intervention
EXPERIMENTALThis group will receive the dietary intervention
Control
NO INTERVENTIONThis group with continue on their usual diet
Interventions
A whole food plant based (WFPB) diet
Eligibility Criteria
You may qualify if:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study visits, procedures, requirements, and availability for the duration of the study
- Women with a surgical, imaging, or clinical diagnosis of endometriosis
- Age 18-45 years
- Stable health condition and medications for the past 3 months
- Modified Biberoglu and Behrman (B\&B) pelvic pain score of at least 5/9
- Willing to be randomly assigned to either an active or a control group
- Agreement to adhere to Lifestyle Considerations throughout the study duration
You may not qualify if:
- Smoking or drug abuse during the past six months
- Alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
- Already following a WFPB diet
- Pregnant or breastfeeding, or plans of pregnancy within the study period
- Hysterectomy or ovariectomy
- Fibroids, ovarian cysts, pelvic inflammatory disease
- Endocrine inflammatory conditions, such as Cushing's syndrome, Hashimoto's thyroiditis, Graves' disease, type 1 diabetes mellitus, and Addison's disease
- Evidence of an eating disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCSD Health
La Jolla, California, 92093, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sanjay K Agarwal, MD
UCSD
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
July 22, 2025
First Posted
July 29, 2025
Study Start
November 1, 2025
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
October 1, 2029
Last Updated
April 28, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
It will be proprietary